Division of C,linical Sciences, Imperial College London
Doi
Abstract
Plasma cells are the terminally differentiated effector cells of the humoral
immune system. The majority of plasma cells are short-lived and undergo
programmed cell death in the form of apoptosis after few days of intensive
immunoglobulin secretion. Despite potentially wide-ranging implications for
infection control, auto-immunity, and plasma cell dyscrasias, the mechanisms
that govern the initiation and execution of plasma cell apoptosis are poorly
understood. In this study, it was found that a sharp increase in endoplasmic
reticulum (ER) stress and a substantially decreased tolerance to survive ER
stress occur in plasma cells that have completed differentiation and begin to
undergo apoptosis. Caspase-12, which has been linked specifically to ER stressinduced
apoptosis, is activated during programmed plasma cell death and
mediates apoptotic DNA fragmentation and chromatin condensation. In contrast,
the major apoptotic effector caspases downstream of the mitochondria become
resistant to activation during terminal plasma cell differentiation and are not
activated during plasma cell apoptosis. Caspase-3, which acts as the major
executioner of apoptosis in most cells, becomes stabilized in its inactive form in
plasma cells and human myeloma cell lines. Immunohistochemistry of human
lymphoid tissue sections demonstrated that primary plasma cells and myeloma
cells undergo spontaneous apoptosis in vivo without activation of caspase-3.
Using mouse embryonic fibroblasts double-deficient in caspase-3 and caspase-7,
it was found that lack of active executioner caspases substantially delays but does not prevent ER stress-induced apoptosis. These observations suggest that
developmentally regulated inhibition of key apoptotic caspases has evolved in
plasma cells as a means to delay apoptosis under conditions of ER stress that is
linked to immunoglobulin secretion. Overwhelming ER stress ultimately limits the
life-span of short-lived plasma cells by inducing apoptosis using alternative
mechanism involving caspase-12, which mediates nuclear apoptotic events